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BACKGROUND. Adjuvant radiation has been proposed for the treatment of patients
with desmoplastic melanoma, who reportedly have local recurrence rates as high
as 40 – 60%. The authors investigated local recurrence rates at a tertiary referral
center to determine the success of wide excision alone for patients with desmo-
plastic melanoma.
METHODS. A review of a prospectively maintained melanoma clinical data base
identified 65 patients between March 1997 and March 2004 with pure cutaneous
desmoplastic melanoma. Complete surgical, histopathologic, and staging informa-
tion was collected along with data on outcome, including local, regional, and
distant recurrence and survival.
RESULTS. Similar to previous reports, patients with desmoplastic melanoma had a
male-to-female ratio of 2 to 1, a mean age of 65.0 years (range, 31–92 yrs), and the
majority of their tumors (55%) were located on the head and neck. The mean
Breslow depth at diagnosis was 4.21 mm, with 38% of tumors thicker than 4.0 mm.
All patients in this series underwent wide excision without radiation therapy.
Surgical margins  2 cm were obtained for all trunk and extremity lesions and for
63% of head and neck lesions that measured  1 mm in depth (63%). Margins of
1–2 cm were obtained for the remaining patients. Among 49 patients who had a
minimum of 2 years of follow-up (mean, 3.7 yrs), the local recurrence rate was 4%
(2 of 49 patients). Seventy-eight percent of the patients studied remained alive with
no evidence of disease.
CONCLUSIONS. Local recurrence rates in the current series were considerably lower
than the historically reported rates. This finding suggests that, for patients with
desmoplastic melanoma, wide local excision with careful attention to appropriate
margins produces excellent local control rates without the need for adjuvant
radiation. Cancer 2005;104:1462–7. © 2005 American Cancer Society.
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S ince it was described originally by Conley et al. in 1971, desmo-plastic melanoma has been reported as a locally aggressive tumor
in the literature.1 Conley and colleagues described this melanoma
subtype as typically a bulky, subcutaneous tumor that recurred fre-
quently and metastasized often. In view of the dense fibrosis accom-
panying the spindle cell tumor, those authors proposed the term
desmoplastic malignant melanoma. Eight years later, Reed and Leo-
nard noted that spindle cell melanomas exhibiting desmoplasia also
demonstrated neurotropism and a “dominant neuroid appearance”2
and proposed the term neurotropic melanoma for this variant of
spindle cell melanoma. Today, it is recognized that both desmoplastic
melanoma and neurotropic melanoma represent rare variants of mel-
anoma that are part of a histologic continuum.
Desmoplastic melanoma is regarded as a locally aggressive mel-
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anoma subtype with local recurrence rates as high as
40 – 60%.3– 6 For this reason, adjuvant radiotherapy has
been advocated by some for local control.6,7 A Phase II
trial to evaluate the benefit of adjuvant radiation has
been initiated by the North Central Cancer Treatment
Group. Because our institution does not utilize adju-
vant radiation routinely in the management of mela-
noma, we sought to determine local recurrence rates
for patients with desmoplastic melanoma who under-
went wide excision alone. Here, we report that, with
wide excision alone and careful pathologic examina-
tion of margins, excellent local control of desmoplastic
melanoma can be achieved.
MATERIALS AND METHODS
A review was performed of a prospectively maintained
melanoma clinical data base at the University of Mich-
igan Multidisciplinary Melanoma Clinic with Institu-
tional Review Board approval. Between March 1997
and March 2004, 79 patients were identified with pure
desmoplastic/desmoplastic neurotropic melanoma or
other histologic subtypes with desmoplastic features.
Clinical data were reviewed for all patients. His-
topathologic review of all tumor specimens, including
materials from referring institutions, was conducted
by dermatopathologists at the University of Michigan.
Of the 79 lesions identified, 66 were pure desmoplastic
or desmoplastic/neurotropic melanomas. A pure des-
moplastic melanoma was defined as melanoma com-
posed of variably atypical, spindled-to-fusiform mela-
nocytes associated with a prominent collagenous or
desmoplastic stroma, with or without neurotropism.
Spindle cell melanomas without intratumoral desmo-
plasia were excluded from this study. Sixty-five lesions
were cutaneous, and 1 lesion was mucosal (retromo-
lar). The current review was limited to the 65 cutane-
ous pure desmoplastic melanomas, with and without
neurotropism.
All patients underwent definitive management at
the University of Michigan with wide local excision.
For all melanomas that measured  2.0 mm in
Breslow depth, the objective of wide excision was a
margin of 2.0 cm. For lesions between 1.0 mm and 2.0
mm in Breslow depth, margins of at least 1.0 cm were
obtained if 2.0-cm margins were not possible. Margins
of 1.0 cm were taken around lesions that measured
 1.0 mm in depth. Forty-three patients (67%) under-
went lymphatic mapping with sentinel lymph node
biopsy (SLNB). The technique of SLNB has been de-
scribed previously.8 Follow-up information from the
date of definitive treatment was obtained through the
University of Michigan Cancer Registry.
RESULTS
We identified 65 patients with pure desmoplastic mel-
anoma who were treated at the University of Michigan
between 1997 and 2004 (Table 1). Neurotropism was
present in 21 lesions (32%) and was absent in 44
lesions (68%). Forty-four patients were male, and the
male-to-female ratio was 2.1:1.0. The median age at
presentation was 65.0 years (range, 31–92 yrs). Seventy-
five percent of the patients were age 50 years or older.
More than one-half of the lesions (55%) were located
on the head and neck. Eighteen percent of the lesions
were located on the trunk, 20% were located on the
upper extremity, and only 4 lesions (6%) were located
on the lower extremity.
It was rare for desmoplastic melanoma to be de-
tected at a thin stage. Only 7 patients (11%) had mel-
anomas that measured  1.0 mm. Twenty-five pa-
tients (38%) had thick melanomas ( 4.0 mm). Six of
the seven thin melanomas were located on easily vis-
ible areas (two on the neck, one on the forehead, and
three on the arm). In contrast, the thicker melanomas
TABLE 1
Clinical and Pathologic Characteristics of 65 Patients with
Desmoplastic Melanoma





 40 yrs 5 (8)
40–50 yrs 11 (17)
50–60 yrs 11 (18)
60–70 yrs 12 (18)
 70 yrs 26 (40)
Location
Head and neck 36 (55)
Trunk 12 (18)
Upper extremity 13 (20)
Lower extremity 4 (6)
Breslow depth
 1.00 mm 7 (11)
1.01–2.00 mm 19 (29)
2.01–4.00 mm 14 (21)









 1/mm2 28 (43)
1–5/mm2 23 (35)
 5/mm2 5 (8)
Unknown 9 (14)
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were located more often on the scalp, posterior neck,
or back (13 of 25 thick melanomas were in these
locations). Despite the advanced Breslow depth, other
histologic prognostic factors were not dramatically
worse. Ulceration was present in only 9 lesions (14%),
and 28 lesions (42%) had a mitotic rate  1/mm2. Even
among the 25 thick melanomas, 18 lesions had no
ulceration, and 15 lesions had mitotic rates  1/mm2.
For the current review, we included pure desmo-
plastic melanoma with or without neurotropism. Neu-
rotropism was present in 21 lesions (32%). Age and
gender distribution was equal between desmoplastic
melanomas with or without neurotropism. Neurotro-
pism was found less commonly when the melanoma
was located on the extremities versus lesions located
on the trunk or head and neck (15% vs. 32%). Desmo-
plastic neurotropic melanomas had a thicker Breslow
depth at presentation than desmoplastic melanoma
without neurotropism (5.96 mm vs. 3.05 mm; P
 0.0006). There was no difference in the presence of
ulceration or the mitotic rate.
All patients underwent a wide excision. For le-
sions on the head and neck, a margin  2.0 cm was
obtained in 20 of 32 patients who had lesions that
measured  1.0 mm in depth (63%). Of the remaining
12 patients, margins  2.0 cm but  1.0c m were
obtained, and 8 of those patients had lesions that
measured between 1.00 mm and 2.00 mm in Breslow
depth. In one patient, only narrow margins were taken
near the eyelid. The three patients who had head and
neck lesions that measured  1.0 mm had 1.0-cm
excision margins; and, in 1 patient, the margins of
resection were unknown. To obtain these margins,
almost all patients (30 of 36 patients) who had head
and neck lesions required reconstruction with a com-
plex closure, advancement flaps, or skin grafts. For
lesions on the trunk or extremities, 2.0-cm margins
were obtained for all patients who had melanomas
that measured  2.0 mm in Breslow depth. Five pa-
tients required split-thickness skin grafts for closure.
One patient who had a desmoplastic melanoma on
the arm that measured 0.6 mm in Breslow depth had
margins of 1.0 cm; however, the patient underwent
reexcision, because the trailing edge of melanoma in
situ was present in the peripheral margins.
One of 65 patients who presented with clinically
involved lymph nodes underwent a complete lymph
node dissection at the time of wide local excision. This
patient had a 19-mm lesion located on the upper back
with a palpable lymph node in the right axilla. Two of
26 lymph nodes were positive on axillary lymph node
dissection. The patient had an in-transit recurrence 8
months later but, after resection, remained alive with-
out evidence of recurrence 1 year later. Of the remain-
ing 64 patients, 43 patients (67%) underwent SLNB.
Four patients had positive SLNB results (9%). With an
overall mean follow-up of 2.7 years, 2 patients who
had negative SLNB results developed regional recur-
rences. One patient had a forehead lesion that mea-
sured 9 mm in Breslow depth and had a negative
preauricular sentinel lymph node. He developed a
recurrence with simultaneous cervical and pulmonary
metastases and died of disease. The second patient,
who had a lower back lesion that measured 7 mm in
Breslow depth with a negative inguinal sentinel lymph
node, developed recurrent disease in the iliac lymph
nodes. He remained disease-free after undergoing su-
perficial and deep inguinal dissection. This resulted in
a false-negative rate of 33% (2 false negative results
among 6 lymph node-positive patients) and a negative
predictive value of 95%. Of the 21 patients who un-
derwent wide excision alone, 1 patient had a regional
recurrence: He developed distant disease shortly after
that and died of his disease.
Of the 44 patients who had lesions without neu-
rotropism, 1 patient was clinically lymph node posi-
tive, and 28 patients underwent SLNB, which pro-
duced 1 positive result. To date, no patient has
developed a regional recurrence. Of the 21 patients
who had lesions with neurotropism, 15 patients un-
derwent SLNB, which produced 3 positive results.
Both regional recurrences after a negative SLNB were
in patients who had lesions with neurotropism, which
was the same as the regional recurrence in the patient
who underwent wide excision alone. Therefore, with a
median follow-up of 2.7 years, lymph node metastases
were present in only 4% of patients who had desmo-
plastic melanomas without neurotropism but were
present in 28% of patients who had desmoplastic mel-
anomas with neurotropism (P  0.01).
Among the cohort of 65 patients with pure des-
moplastic melanoma who underwent wide local exci-
sion alone without radiation therapy, 5 patients were
lost to follow-up, and 11 patients were treated within
the past 2 years (none of whom has had a local recur-
rence). This leaves 49 patients with a minimum of 2
years of follow-up after therapy and a mean follow-up
of 3.6 years. This subset has a profile similar to that of
the full cohort (Table 2). Among these patients, there
have been only 2 local recurrences (4%), both of which
were head and neck lesions. The first local recurrence
was in a patient who had a lesion on the scalp that
measured 8.5 mm in Breslow depth. The second local
recurrence was in a patient who had a lesion on the
temple that measured 5.0 mm in Breslow depth. Both
recurred adjacent to the previous scar or skin graft
site. Of the two local recurrences, one patient had
neurotropism in the primary tumor and one did not.
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Both patients underwent resection of their recur-
rences and remain disease free. Three patients devel-
oped distant metastases and died of their disease (6%),
and 6 patients died of other causes (12%). Thirty eight
patients (78%) remain alive with no evidence of dis-
ease.
DISCUSSION
Desmoplastic melanoma is an uncommon variant of
cutaneous melanoma, comprising approximately 4%
of lesions.9 Several reports of desmoplastic melanoma
have painted a uniform picture of the disease: specif-
ically, these lesions are more common on the head
and neck, they occur more often in men than in
women, and they affect an older age group. The dis-
ease rarely is diagnosed early, often because it lacks
the classic physical findings associated with mela-
noma and more frequently is amelanotic. In this re-
gard, our series from the University of Michigan con-
forms to this description. Concordant with the prior
observations, our population of patients with desmo-
plastic melanoma demonstrated a male preponder-
ance of 2:1 and a considerably older age at presenta-
tion, with a median age of 65 years. Head and neck
was the most common site disease by far, and they
presented at an advanced Breslow depth, with a mean
depth of 4.22 mm.
In addition to the clinical characteristics de-
scribed above, it has been shown that desmoplastic
melanoma has an unusually high local recurrence rate
and a low rate of metastasis to regional lymph nodes.
Based on these observations, some even have sug-
gested that desmoplastic melanoma has more in com-
mon with soft tissue sarcomas than cutaneous mela-
noma.10,11 Because of the reportedly high local
recurrence rates, some authors have suggested surgi-
cal margins of up to 3.0 cm4,5,9,12 with the use of
adjuvant radiation.6,7
Indeed, desmoplastic melanoma does tend to
have a lower incidence of regional metastases. Seven
patients in the current series had regional disease (4
detected on SLNB, 1 clinically evident, and 3 regional
recurrences), for an overall incidence of 11%. Al-
though regional disease is less frequent in desmoplas-
tic melanoma, SLNB still is warranted in clinically
lymph node-negative patients. Lymph node metasta-
sis (as evidenced either by a positive sentinel lymph
node or by clinical lymph node involvement) was sig-
nificantly more common when neurotropism was
present in the primary tumor. However, this may be
related to the thicker Breslow depth seen in desmo-
plastic melanomas with neurotropism.
The primary focus of this review was the local
recurrence rate after wide local excision without radi-
ation, and our results did not confirm the rates de-
scribed by previous studies. The mean time to local
recurrence after wide excision is 12 months6; and
Quinn et al., in their review of 280 patients, found that
 75% of all recurrences occurred within 2 years.9 For
this reason, we limited our evaluation to those pa-
tients who had a minimum of 2 years follow-up (49 of
65 patients). Of these 49 patients, only 2 patients had
local recurrences (4%). A similar finding was reported
recently by investigators at Memorial Sloan-Kettering
Cancer Center, who also found a local recurrence rate
of 4% (1 of 24 patients).10 Similar to our procedure,
they perform wide local excision of at least 2 cm when
possible and do not use local adjuvant radiation ther-
apy routinely. Like all retrospective research, it is pos-
sible to introduce biases. In the current study, it is
possible that there may have been local recurrences in
the 5 patients who were lost to follow-up. However,
even in the unlikely situation that all 5 of those pa-
tients developed local recurrences, the local recur-
rence rate would be 13% (7 of 54 patients), which still
is substantially lower than suggested in the literature.
Although there are several reports in the literature
concerning desmoplastic melanoma that describe
similar presentations (elderly patients, male prepon-
derance, head and neck lesions), they vary widely in
their description of local recurrence rates. The reasons
for this are not entirely clear. One explanation may be
the length of follow-up. However, because most local
recurrences will occur within 2 years,9 it is unlikely
that this is the only explanation. Another explanation
may be the definition of desmoplastic melanoma. Es-
tablishing a correct histologic diagnosis is paramount
and not always straightforward. Dermatopathologists
with experience in the diagnosis of melanoma are
needed, because desmoplastic melanoma can be con-
TABLE 2
Recurrence Rates after Definitive Management of Desmoplastic
Melanoma in 49 Patients with a Minimum of 2 Years of Follow-Up
Characteristic No. of patients (%)
Location
Head and neck 26 (53)
Trunk 9 (18)
Upper extremity 10 (20)





Local recurrence rate 2 (4)
Distant recurrences 3 (6)
Died without disease 6 (11)
Two-yr disease-free survival (%) 78
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fused with scar, blue nevus, neurofibroma, dermato-
fibroma, schwannoma, fibromatosis, or spindle cell
sarcoma. Failure to diagnose properly may lead to a
high risk of local recurrence due to inadequate mar-
gins. It is possible that some older series with high
local recurrence rates may have included some of
these other lesions. In the current series, all pathologic
specimens were reviewed to confirm the diagnosis of
desmoplastic melanoma.
The most likely possibility for the discrepancy in
high recurrence rates described may be attributable to
the margins obtained at surgery and/or the his-
topathologic examination of those margins. Because
many of these lesions will occur in the head and neck
region, surgeons may be hesitant to obtain margins of
1–2 cm. It has been well documented that local recur-
rence is significantly greater for desmoplastic mela-
noma when margins  1 cm are obtained.9,12 In many
series that reported high local recurrence rates with-
out radiation, the surgical margins obtained were not
quantifiable; were described only as “negative” or
“unknown”; and, in several patients, had positive mar-
gins but were not reexcised (Table 3). Often, these
series included patients who underwent “excision” at
outside hospitals and who presented at the time of
their local recurrence, which may result in a false
elevation of the tertiary hospital’s recurrence rate.
In addition to obtaining adequate margins in the
operating room, careful histopathologic review of the
specimen is necessary. Desmoplastic melanoma often
arises within lentigo maligna.13 Not infrequently, the
trailing edge of lentigo maligna subtly blends with
surrounding, up-regulated melanocytes in sun-dam-
aged skin, complicating the histologic assessment of
the surgical margins. Failure to recognize and identify
this atypical junctional melanocytic hyperplasia,
which often is part of the trailing edge of lentigo ma-
ligna, may result in inadequate peripheral margin
control and a theoretically higher rate of local recur-
rence.14,15 Neurotropism also is a histologic feature
that has been associated with increased local recur-
rence rates.4,5,9,16 The neurotropic variant has a pre-
dilection for invasion along nerves. Thus, careful ex-
amination of the specimen for the presence of
neurotropism and for perineural involvement at the
resection margins is important to obtain adequate
surgical margins and prevent local recurrence. In the
current series, neurotropism was not associated with
TABLE 3








MSKCC (Gyorki et al., 200310) 2003 27 (median) 27 4 The 1 LR was seen in a patient who underwent
excision of an 8-mm Clark Level V cheek
melanoma with a close but negative deep
margin at original excision
University of Michigan 2004 42 (median) 49 4 Both LRs were thick melanomas on the head and
neck
Sydney Melanoma Unit (Quinn et al., 19989) 1998 NA 280 11 The LR rate was higher when the surgical
clearance margin was  1 cm and when
neurotropism was present
University of South Florida (Payne et al., 200118) 2001 18 (mean) 30 23 Margins of excision are not described
Massachusetts General Hospital (Carlson et al., 199519) 1995 24 (median) 28 25 Two of 7 locally recurring lesions had only positive
margin biopsies, 1 had margins  1 cm, and 1
had unknown margins
University of Queensland (Smithers et al., 199212) 1992 30 (median) 58 29 Margins of excision were unknown
Mayo Clinic (Jaroszewski et al., 20013) 2001 NA 59 39 LR correlated with positive, unknown, or  1 cm
margins
University of California at San Francisco (Egbert et al.,
19884)
1988 32.4 (mean) 25 48 Eight of 12 patients with locally recurrent lesions
either were diagnosed initially with a benign
lesion or did not undergo histologic
examination of the initial excision specimen;
recurrence may be related to inadequate initial
therapy
Queen Elizabeth Hospital (Jain and Allen, 19895) 1989 55 (mean) 45 55 Margins of excision were unknown, and several
lesions were excised with positive or close
margins; recurrence may be related to
inadequate initial therapy
LR: local recurrence; MSKCC: Memorial Sloan-Kettering Cancer Center; NA: not available.
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an increased local recurrence rate, although it did
correlate with lymph node metastases.
Also, it is not always easy to identify the extent of
desmoplastic melanoma on histopathologic examina-
tion. In some tumors, the cells demonstrate only mild
atypia and can have a subtle, infiltrative pattern of
growth. If margins  2.0 cm are taken to avoid a skin
graft or because of proximity to difficult structures,
then a detailed histopathologic examination of all sur-
gical margins should be performed. Reexcision is rec-
ommended for any areas in which the lesion approx-
imates a margin, including for early lentigo maligna or
atypical junctional melanocytic hyperplasia. In several
series that demonstrated high local recurrence rates,
many of these areas were attributed to the failure to
recognize and obtain clear surgical margins.9,12,17
Based on previous reports, the use of adjuvant
radiotherapy has been recommended after surgery to
reduce local recurrence rates. A Phase II trial of post-
operative radiotherapy after wide local excision is be-
ing initiated by the North Central Cancer Treatment
Group. The low local recurrence rate achieved in the
current study may provide useful information with
respect to what local recurrence rate with adjuvant
radiation therapy would justify the further evaluation
of postoperative radiation in a Phase III trial. The
results of these recent reviews suggest that excellent
local control may be obtained with surgery alone.
Although this may require the use of 2.0-cm surgical
margins for lesions that measure  1.0 mm in Breslow
depth and a more thorough histopathologic review of
the surgical specimen, which is not without added
cost and time, it certainly is worth considering, be-
cause it may improve local control rates and spare
patients the cost and morbidity of adjuvant radiother-
apy.
Local recurrences are more common for head and
neck melanomas, possibly due to the inherent diffi-
culties of wide local excision at this anatomic site.
Because lesions on the trunk and extremities can be
resected easily with 2-cm margins, there should be
little indication for radiotherapy after patients un-
dergo resection with clear margins and with careful
histologic assessment of trunk or extremity desmo-
plastic melanomas. In anatomically critical regions of
the head and neck, the surgeon should attain up to
2-cm margins whenever feasible, and every effort
should be made to clear the surgical margin. When
anatomic considerations prevent the surgeon from
achieving adequate surgical margins due to proximity
to critical structures or after resection of a locally
recurrent desmoplastic melanoma, radiation may be
considered and potentially may be beneficial. Radia-
tion also should be considered for lesions that are
unresectable at presentation. Otherwise, the routine
use of radiation as an adjuvant to surgery for desmo-
plastic melanoma, even for head and neck lesions,
should not be necessary.
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